Debra Durso Bumpus Blueprint Medicines Corp (BPMC) insider trading activity

Debra Durso Bumpus is Chief People Officer of Blueprint Medicines Corp. Currently has a direct ownership of 0 shares of BPMC, which is worth approximately $0. The most recent transaction as insider was on Jul 17, 2025, when has been sold 51,103 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Debra Durso-Bumpus Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 17 2025	SELL Sale (or disposition) back to the issuer	-	51,103 Reduced 72.02%	19,856 Common Stock
Jul 17 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	19,856 Reduced 100.0%	0 Common Stock
Jul 17 2025	BUY Grant, award, or other acquisition	-	21,353 Added 23.13%	70,959 Common Stock
Mar 05 2025	SELL Open market or private sale	$457,941 $88.8 p/Share	5,157 Reduced 9.42%	49,606 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	11,000 Added 16.73%	54,763 Common Stock
Jul 05 2024	SELL Open market or private sale	$428,120 $111.2 p/Share	3,850 Reduced 8.09%	43,763 Common Stock
Jul 05 2024	BUY Exercise of conversion of derivative security	$208,400 $54.13 p/Share	3,850 Added 7.48%	47,613 Common Stock
Jul 03 2024	SELL Open market or private sale	$981,243 $111.29 p/Share	8,817 Reduced 16.77%	43,763 Common Stock
Jul 03 2024	BUY Exercise of conversion of derivative security	$477,264 $54.13 p/Share	8,817 Added 14.36%	52,580 Common Stock
Jun 28 2024	SELL Open market or private sale	$37,012 $111.15 p/Share	333 Reduced 0.76%	43,763 Common Stock
Jun 28 2024	BUY Exercise of conversion of derivative security	$18,025 $54.13 p/Share	333 Added 0.75%	44,096 Common Stock
Jun 21 2024	SELL Open market or private sale	$7,706,199 $104.09 p/Share	74,034 Reduced 62.85%	43,763 Common Stock
Jun 21 2024	BUY Exercise of conversion of derivative security	$1,908,207 $31.55 p/Share	60,482 Added 33.93%	117,797 Common Stock
Mar 07 2024	SELL Open market or private sale	$461,884 $90.69 p/Share	5,093 Reduced 8.13%	57,585 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	12,500 Added 16.63%	62,678 Common Stock
Mar 06 2023	SELL Open market or private sale	$142,110 $45.0 p/Share	3,158 Reduced 5.92%	50,178 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	12,500 Added 18.99%	53,336 Common Stock
Aug 24 2022	SELL Open market or private sale	$375,550 $75.11 p/Share	5,000 Reduced 10.91%	40,836 Common Stock
Aug 24 2022	BUY Exercise of conversion of derivative security	$75,050 $15.01 p/Share	5,000 Added 9.84%	45,836 Common Stock
Mar 07 2022	SELL Open market or private sale	$58,831 $56.19 p/Share	1,047 Reduced 2.5%	40,836 Common Stock
Mar 03 2022	SELL Open market or private sale	$89,863 $60.27 p/Share	1,491 Reduced 3.44%	41,883 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	12,500 Added 22.37%	43,374 Common Stock
Nov 01 2021	SELL Open market or private sale	$584,535 $112.91 p/Share	5,177 Reduced 14.36%	30,874 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$139,934 $27.03 p/Share	5,177 Added 12.56%	36,051 Common Stock
Sep 23 2021	SELL Open market or private sale	$93,288 $110.01 p/Share	848 Reduced 2.67%	30,874 Common Stock

Debra Durso Bumpus

Chief People Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Value

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC

Account